Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP289933.RAzIaXFOnSKi9iGgE16g9pB4TrIVvU_0bSfTDBnO-CTL0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP289933.RAzIaXFOnSKi9iGgE16g9pB4TrIVvU_0bSfTDBnO-CTL0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP289933.RAzIaXFOnSKi9iGgE16g9pB4TrIVvU_0bSfTDBnO-CTL0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP289933.RAzIaXFOnSKi9iGgE16g9pB4TrIVvU_0bSfTDBnO-CTL0130_provenance.
- NP289933.RAzIaXFOnSKi9iGgE16g9pB4TrIVvU_0bSfTDBnO-CTL0130_assertion description "[Our results demonstrate tumor-specific accumulation and therapeutic efficacy of radioiodine after MSC-mediated NIS gene delivery in HCC tumors, opening the prospect of NIS-mediated radionuclide therapy of metastatic cancer using MSCs as gene delivery vehicles.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP289933.RAzIaXFOnSKi9iGgE16g9pB4TrIVvU_0bSfTDBnO-CTL0130_provenance.
- NP289933.RAzIaXFOnSKi9iGgE16g9pB4TrIVvU_0bSfTDBnO-CTL0130_assertion evidence source_evidence_literature NP289933.RAzIaXFOnSKi9iGgE16g9pB4TrIVvU_0bSfTDBnO-CTL0130_provenance.
- NP289933.RAzIaXFOnSKi9iGgE16g9pB4TrIVvU_0bSfTDBnO-CTL0130_assertion SIO_000772 21587211 NP289933.RAzIaXFOnSKi9iGgE16g9pB4TrIVvU_0bSfTDBnO-CTL0130_provenance.
- NP289933.RAzIaXFOnSKi9iGgE16g9pB4TrIVvU_0bSfTDBnO-CTL0130_assertion wasDerivedFrom befree-20140225 NP289933.RAzIaXFOnSKi9iGgE16g9pB4TrIVvU_0bSfTDBnO-CTL0130_provenance.
- NP289933.RAzIaXFOnSKi9iGgE16g9pB4TrIVvU_0bSfTDBnO-CTL0130_assertion wasGeneratedBy ECO_0000203 NP289933.RAzIaXFOnSKi9iGgE16g9pB4TrIVvU_0bSfTDBnO-CTL0130_provenance.
- befree-20140225 importedOn "2014-02-25" NP289933.RAzIaXFOnSKi9iGgE16g9pB4TrIVvU_0bSfTDBnO-CTL0130_provenance.